Diagnosis and Management of Pericardial Diseases

Dear Colleagues,

Pericardial diseases, often referred to as the "Cinderella of heart disease", represent a challenging and contemporary issue for clinicians worldwide. Not only have we observed a constant rise in the number of cases in recent years, but patients are also showing increasing resistance to conventional treatments, especially after experiencing multiple pericarditis recurrences. The situation was exacerbated during the recent SARS-CoV-2 pandemic, with a significant upsurge in pericarditis cases, possibly linked to viral infections and, to a lesser extent, vaccination. This alarming trend has not only encouraged increased awareness but also ignited further research in this crucial clinical setting.

In the last few years, we have witnessed exciting developments, particularly with the advent of promising biological drugs, such as IL-1 inhibitors, which have been assessed in clinical studies. Additionally, researchers have delved into advanced diagnostic and prognostic assessments for pericardial diseases, enabling more precise and tailored patient care.

In light of these significant advancements, this Special Issue aims to gather and present the most recent breakthroughs in the diagnosis and management of pericardial diseases. Our goal is to equip clinicians with updated information that can be readily translated into their clinical practice, thus enhancing patient outcomes.

Dr. Alessandro Andreis
Prof. Dr. Massimo Imazio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.